AquaBounty Technologies, Inc. (AQB) Stock
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About AquaBounty Technologies, Inc.
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
AquaBounty Technologies, Inc. is led by CEO David A. Frank, employs 4 people, headquartered in US, publicly traded since 2017.
AquaBounty Technologies, Inc. (AQB) stock trades at $0.90 with a market capitalization of $4.63M. The stock is valued at a price-to-earnings (P/E) ratio of -0.18, price-to-book of -1.95, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.70 and $2.95, and currently trades 69.5% below its 52-week high.
On profitability, AquaBounty Technologies, Inc. generates a return on equity (ROE) of -368.03%, return on capital employed of -107.57%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.aquabounty.com